- Home
- SON vs KRYS Comparison
SON vs KRYS Comparison
Compare SON & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SON
- KRYS
- Stock Information
- Founded
- SON 1899
- KRYS 2015
- Country
- SON United States
- KRYS United States
- Employees
- SON N/A
- KRYS N/A
- Industry
- SON Containers/Packaging
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SON Consumer Discretionary
- KRYS Health Care
- Exchange
- SON Nasdaq
- KRYS Nasdaq
- Market Cap
- SON 5.1B
- KRYS 4.5B
- IPO Year
- SON N/A
- KRYS 2017
- Fundamental
- Price
- SON $49.24
- KRYS $151.55
- Analyst Decision
- SON Buy
- KRYS Strong Buy
- Analyst Count
- SON 6
- KRYS 7
- Target Price
- SON $60.17
- KRYS $206.67
- AVG Volume (30 Days)
- SON 759.9K
- KRYS 276.8K
- Earning Date
- SON 02-12-2025
- KRYS 02-24-2025
- Dividend Yield
- SON 4.25%
- KRYS N/A
- EPS Growth
- SON N/A
- KRYS N/A
- EPS
- SON 2.91
- KRYS 1.77
- Revenue
- SON $6,572,688,000.00
- KRYS $241,519,000.00
- Revenue This Year
- SON N/A
- KRYS $485.81
- Revenue Next Year
- SON $16.95
- KRYS $58.65
- P/E Ratio
- SON $16.79
- KRYS $85.13
- Revenue Growth
- SON N/A
- KRYS 2722.80
- 52 Week Low
- SON $45.93
- KRYS $107.50
- 52 Week High
- SON $61.73
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- SON 54.09
- KRYS 41.79
- Support Level
- SON $46.89
- KRYS $141.72
- Resistance Level
- SON $47.95
- KRYS $152.94
- Average True Range (ATR)
- SON 0.94
- KRYS 5.40
- MACD
- SON 0.20
- KRYS 0.08
- Stochastic Oscillator
- SON 97.78
- KRYS 49.17
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.